High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.

High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.

Show other versions (1)

OBJECTIVE: Maturity-onset diabetes of the young (MODY) as a result of mutations in hepatocyte nuclear factor 1-α (HNF1A) is often misdiagnosed as type 1 diabetes or type 2 diabetes. Recent work has shown that high-sensitivity C-reactive protein (hs-CRP) levels are lower in HNF1A-MODY than type 1 dia...

书目详细资料
Main Authors:	McDonald, T, Shields, B, Lawry, J, Owen, K, Gloyn, A, Ellard, S, Hattersley, A
格式:	Journal article
语言:	English
出版:	2011

相似书籍

High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
由: McDonald, T, et al.
出版: (2011)

Response to Comment on: McDonald et al. High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes. Diabetes Care 2011;34:1860-1862.
由: McDonald, T, et al.
出版: (2011)

Lipoprotein composition in HNF1A-MODY: differentiating between HNF1A-MODY and type 2 diabetes.
由: McDonald, T, et al.
出版: (2012)

No attenuation of CRP response to acute inflammation is seen in HNF1A-MODY
由: Owen, K, et al.
出版: (2013)

Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes.
由: Mughal, SA, et al.
出版: (2013)

HNF1A-MODY is associated with an intact CRP response during human endotoxaemia
由: Mughal, SA, et al.
出版: (2014)

The role of the HNF4alpha enhancer in type 2 diabetes.
由: Mitchell, S, et al.
出版: (2002)

The role of the HNF4α enhancer in type 2 diabetes variants of the HNF4α enhancer are not a common cause of susceptibility to type 2 diabetes
由: Mitchell, S, et al.
出版: (2002)

Cystatin C is not a good candidate biomarker for HNF1A-MODY.
由: Nowak, N, et al.
出版: (2013)

Cystatin C is not a good candidate biomarker for HNF1A-MODY
由: Nowak, N, et al.
出版: (2013)

Integration of biomarkers and clinical characteristics provides the best method for identifying patients with MODY
由: Shields, B, et al.
出版: (2012)

Biomarkers: Tools for discriminating MODY from other diabetic subtypes
由: Parveena Firdous, et al.
出版: (2022-01-01)

Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.
由: Owen, K, et al.
出版: (2010)

Altered cortisol metabolism in individuals with HNF1A-MODY
由: Juszczak, A, et al.
出版: (2020)

Asian MODY: are we missing an important diagnosis?
由: Porter, JR, et al.
出版: (2006)

Variants influencing age at diagnosis of HNF1A-MODY
由: Agnieszka H. Ludwig-Słomczyńska, et al.
出版: (2022-09-01)

Keeping diabetes in the family: Lessons from a family with HNF-1α MODY
由: Selwood, M, et al.
出版: (2008)

Species-specific differences in the expression of the HNF1A, HNF1B and HNF4A genes.
由: Harries, L, et al.
出版: (2009)

The previously reported T342P GCK missense variant is not a pathogenic mutation causing MODY
由: Steele, A, et al.
出版: (2011)

The previously reported T342P GCK missense variant is not a pathogenic mutation causing MODY.
由: Steele, A, et al.
出版: (2011)

The common p.R114W HNF4A mutation causes a distinct clinical subtype of monogenic diabetes
由: Laver, T, et al.
出版: (2016)

Homozygous hypomorphic HNF1A alleles are a novel cause of young-onset diabetes and result in sulphonylurea sensitive diabetes
由: Misra, S, et al.
出版: (2020)

Lipid profile indices in young people with GCK-MODY and HNF1A-MODY
由: Alla K. Ovsyannikova, et al.
出版: (2022-01-01)

Identification of 21 novel glucokinase (GCK) mutations in UK and European Caucasians with maturity-onset diabetes of the young (MODY).
由: Thomson, K, et al.
出版: (2003)

Genetic testing for glucokinase mutations in clinically selected patients with MODY: a worthwhile investment
由: S Schnyder, et al.
出版: (2005-06-01)

Species-specific differences in the expression of the HNF1A, HNF1B and HNF4A genes.
由: Lorna W Harries, et al.
出版: (2009-11-01)

Low frequency variants in the exons only encoding isoform A of HNF1A do not contribute to susceptibility to Type 2 diabetes
由: Jafar-Mohammadi, B, et al.
出版: (2009)

Low frequency variants in the exons only encoding isoform A of HNF1A do not contribute to susceptibility to type 2 diabetes.
由: Jafar-Mohammadi, B, et al.
出版: (2009)

Maturity-onset diabetes of the young caused by a balanced translocation where the 20q12 break point results in disruption upstream of the coding region of hepatocyte nuclear factor-4alpha (HNF4A) gene.
由: Gloyn, A, et al.
出版: (2002)

Plasma fucosylated glycans and C-reactive protein as biomarkers of HNF1A-MODY in young adult–onset nonautoimmune diabetes
由: Juszczak, A, et al.
出版: (2018)

Novel insights into genetics and clinics of the HNF1A-MODY
由: Valkovicova Terezia, et al.
出版: (2019-04-01)

An Atypical HNF4A Mutation Which Does Not Conform to the Classic Presentation of HNF4A-MODY
由: Andrew J. Spiro, et al.
出版: (2018-01-01)

Description of clinical cases of the familial form of diabetes mellitus HNF1A-MODY
由: A. A. Baranova, et al.
出版: (2021-06-01)

Efficacy of metformin versus sulfonylurea derivative in HNF4A-MODY
由: Nicole Oosterom, et al.
出版: (2022-01-01)

Circulating CD36 is reduced in HNF1A-MODY carriers.
由: Siobhan Bacon, et al.
出版: (2013-01-01)

Early Onset of Mody5 Due to Haploinsufficiency of HNF1B
由: Carmen Bustamante, MD, et al.
出版: (2020-09-01)

Role of low frequency variants in HNF1A exons 8-10 encoding hepatocyte nuclear factor-1 alpha isoform A to susceptibility to Type 2 diabetes
由: Jafar-Mohammadi, B, et al.
出版: (2010)

Granuloma annulare and necrobiosis lipoidica in a patient with HNF1A-MODY
由: Gabriela Irene Garcia Brandes, et al.
出版: (2022-05-01)

Comparison of Glomerular Filtration Rate Estimation from Serum Creatinine and Cystatin C in HNF1A-MODY and Other Types of Diabetes
由: Magdalena Szopa, et al.
出版: (2015-01-01)

When is it MODY? Challenges in the Interpretation of Sequence Variants in MODY Genes
由: Althari, S, et al.
出版: (2016)